figshare
Browse
V72_75_Vaccine. 2019 Feb 21;37(9) 1209-1218.mp4 (190.6 MB)

Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine

Download (190.6 MB)
media
posted on 2019-08-09, 12:00 authored by Terry Nolan, Maria Elena Santolaya, Ferdinandus de Looze, Helen MarshallHelen Marshall, Peter Richmond, Sam Henein, Paul Rheault, Ken Heaton, KIRSTEN PERRETTKIRSTEN PERRETT, Hartley Garfield, Anil Gupta, Murdo Ferguson, Diego D'Agostino, Daniela ToneattoDaniela Toneatto, Miguel O’Ryan
Video related to the published article in Vaccine: Vaccine. 2019 Feb 21;37(9):1209-1218

Funding

Novartis Vaccines and Diagnostics Inc.

GlaxoSmithKline Biologicals SA

History

Usage metrics

    Categories

    Keywords

    4-component serogroup B meningococcal vaccineadolescentspersistenceimmunogenicitykineticsInfectious Diseases

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC